Marizomib
SIGMA/SML1916 - ≥95% (HPLC), (Salinospora tropica)
Synonym: (1R,4R,5S)
CAS Number: 437742-34-2
Empirical Formula (Hill Notation): C15H20ClNO4
Molecular Weight: 313.78
Linear Formula: C15H20ClNO4
Product Type: Chemical
| assay | ≥95% (HPLC) |
| biological source | (Salinospora tropica) |
| color | white to beige |
| form | powder |
| InChI | 1S/C15H20ClNO4/c1-14-10(7 |
| InChI key | NGWSFRIPKNWYAO-SHTIJGAHSA |
| Quality Level | 100 ![]() |
| shipped in | wet ice |
| SMILES string | ClCC[C@@H]1[C@@]2(OC(=O)[ |
| storage condition | desiccated |
| storage temp. | −20°C |
| Application: | Marizomib has been used as a proteasome inhibitor: • to study its effects on glioblastoma cell lines • to analyze its effects on the aging of killifish brain • to test its effect on protein kinase B (PKB/AKT) levels in multiple myeloma cells |
| Biochem/physiol Actions: | Marizomib a natural product is a marine-derived β-lactone-γ-lactam. It shows therapeutic effects against hematologic and solid tumor malignancies.. It is involved in the activation of caspase-3,-8, and -9, increases the reactive oxygen species (ROS) and promotes apoptosis. Marizomib can cross the blood-brain barrier and might have the potential to treat primary brain tumors. It possesses anti-tumor properties. |
| Biochem/physiol Actions: | Marizomib is a second generation proteasome inhibitor with anti-cancer activity. |
| Biochem/physiol Actions: | Marizomib is a second generation proteasome inhibitor with anti-cancer activity. Marizomib binds irreversibly and potently inhibits all three 20S proteasome subunits. |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥95% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |

